Taizhou Kangping Medical Recalls Antiseptic Towelettes for Sterility Issues
Taizhou Kangping Medical recalled 3.85 million cartons of BZK Antiseptic Towelettes on July 22, 2025. The recall stems from a lack of assurance of sterility, posing a high risk to users. Consumers and healthcare providers must stop using these towelettes immediately.
Hazard Information
Lack of Assurance of Sterility.
What You Should Do
Consumers and healthcare providers should stop using this product immediately. Contact Taizhou Kangping Medical Science And Technology Co., Ltd. or your healthcare provider for guidance. Notification method: Letter
Product Details
The recall involves BZK Antiseptic Towelettes containing benzalkonium chloride 0.13%. The affected lot numbers are 220583459, 230553459, 232743459, 110523, 031524, 052224, and 247793459. These products were distributed in New York.
The Hazard
The recalled antiseptic towelettes lack assurance of sterility. This poses a significant health risk, especially in professional settings where sterility is critical.
Reported Incidents
No specific incidents of illness or injury have been reported at this time. The high hazard level reflects potential risks associated with non-sterile products.
What to Do
Stop using the affected towelettes immediately. Contact Taizhou Kangping Medical Science And Technology Co., Ltd. or your healthcare provider for further guidance.
Contact Information
For more information, reach out to Taizhou Kangping Medical at their official website or via the FDA's recall notice.
Glenmark Pharmaceuticals Inc. recalled 13,824 tubes of Azelaic Acid Gel on September 17, 2025. The recall stems from market complaints regarding a gritty texture. Consumers should stop using the product immediately and contact their healthcare provider.
Skin MD by Dr Monika Kiripolsky recalled its Body Acne Cleanser on September 12, 2025. The recall follows the discovery of elevated benzene levels in the product. This contamination poses a high health risk to consumers in California and Georgia.
Private Label Skin Care recalled its Micronized BPO Gel Cleanser 10% on September 12, 2025. Elevated benzene levels prompted the recall in California and Georgia. Consumers must stop using the product immediately and seek guidance from healthcare providers.